Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYRIAD GENETICS INC Director's Dealing 2015

Dec 14, 2015

32566_dirs_2015-12-14_0ea63093-a17e-4739-923f-0e657f5e285f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2015-12-11

Reporting Person: GILBERT WALTER PHD (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-12-11 Common Stock S 5000.0 $42.23 Disposed 12500 Direct